157 related articles for article (PubMed ID: 32020551)
1. Multigene mutational profiling of biliary tract cancer is related to the pattern of recurrence in surgically resected patients.
Conci S; Ruzzenente A; Simbolo M; Bagante F; Rusev B; Isa G; Lawlor RT; Pedrazzani C; Iacono C; Guglielmi A; Scarpa A
Updates Surg; 2020 Mar; 72(1):119-128. PubMed ID: 32020551
[TBL] [Abstract][Full Text] [Related]
2. Genetic alterations analysis in prognostic stratified groups identified TP53 and ARID1A as poor clinical performance markers in intrahepatic cholangiocarcinoma.
Simbolo M; Vicentini C; Ruzzenente A; Brunelli M; Conci S; Fassan M; Mafficini A; Rusev B; Corbo V; Capelli P; Bria E; Pedron S; Turri G; Lawlor RT; Tortora G; Bassi C; Guglielmi A; Scarpa A
Sci Rep; 2018 May; 8(1):7119. PubMed ID: 29740198
[TBL] [Abstract][Full Text] [Related]
3. Cholangiocarcinoma Heterogeneity Revealed by Multigene Mutational Profiling: Clinical and Prognostic Relevance in Surgically Resected Patients.
Ruzzenente A; Fassan M; Conci S; Simbolo M; Lawlor RT; Pedrazzani C; Capelli P; D'Onofrio M; Iacono C; Scarpa A; Guglielmi A
Ann Surg Oncol; 2016 May; 23(5):1699-707. PubMed ID: 26717940
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the effects of adjuvant concurrent chemoradiotherapy and chemotherapy for resected biliary tract cancer.
Kim H; Heo MH; Kim JY
BMC Gastroenterol; 2020 Jan; 20(1):20. PubMed ID: 31992208
[TBL] [Abstract][Full Text] [Related]
5. Genomic characterization of biliary tract cancers identifies driver genes and predisposing mutations.
Wardell CP; Fujita M; Yamada T; Simbolo M; Fassan M; Karlic R; Polak P; Kim J; Hatanaka Y; Maejima K; Lawlor RT; Nakanishi Y; Mitsuhashi T; Fujimoto A; Furuta M; Ruzzenente A; Conci S; Oosawa A; Sasaki-Oku A; Nakano K; Tanaka H; Yamamoto Y; Michiaki K; Kawakami Y; Aikata H; Ueno M; Hayami S; Gotoh K; Ariizumi SI; Yamamoto M; Yamaue H; Chayama K; Miyano S; Getz G; Scarpa A; Hirano S; Nakamura T; Nakagawa H
J Hepatol; 2018 May; 68(5):959-969. PubMed ID: 29360550
[TBL] [Abstract][Full Text] [Related]
6. Oncological outcomes of surgery for recurrent biliary tract cancer: who are the best candidates?
Sakata J; Nomura T; Aono T; Kitami C; Yokoyama N; Minagawa M; Takizawa K; Miura K; Hirose Y; Ichikawa H; Nagahashi M; Shimada Y; Kobayashi T; Wakai T
HPB (Oxford); 2021 Sep; 23(9):1371-1382. PubMed ID: 33558069
[TBL] [Abstract][Full Text] [Related]
7. Clonal analysis of metachronous double biliary tract cancers.
Omori Y; Aoki S; Ono Y; Kokumai T; Yoshimachi S; Sato H; Kusaka A; Iseki M; Douchi D; Miura T; Maeda S; Ishida M; Mizuma M; Nakagawa K; Mizukami Y; Furukawa T; Unno M
J Pathol; 2024 May; 263(1):113-127. PubMed ID: 38482714
[TBL] [Abstract][Full Text] [Related]
8. HER2 Overexpression as a Poor Prognostic Determinant in Resected Biliary Tract Cancer.
Vivaldi C; Fornaro L; Ugolini C; Niccoli C; Musettini G; Pecora I; Cacciato Insilla A; Salani F; Pasquini G; Catanese S; Lencioni M; Masi G; Campani D; Fontantini G; Falcone A; Vasile E
Oncologist; 2020 Oct; 25(10):886-893. PubMed ID: 32353192
[TBL] [Abstract][Full Text] [Related]
9. Crossing borders: A systematic review with quantitative analysis of genetic mutations of carcinomas of the biliary tract.
Roos E; Soer EC; Klompmaker S; Meijer LL; Besselink MG; Giovannetti E; Heger M; Kazemier G; Klümpen HJ; Takkenberg RB; Wilmink H; Würdinger T; Dijk F; van Gulik TM; Verheij J; van de Vijver MJ
Crit Rev Oncol Hematol; 2019 Aug; 140():8-16. PubMed ID: 31158800
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of ERCC1, ERCC2, XRCC1, and TP53 single nucleotide polymorphisms in patients with early-stage non-small cell lung cancer.
Geredeli C; Artac M; Yildirim S; Inal A; Dede I; Guler T; Boruban MC; Koral L; Karaagac M; Zamani AG; Altinok T; Aribas O; Bozcuk H; Demirkazik A
Tumour Biol; 2015 Jun; 36(6):4279-85. PubMed ID: 25596702
[TBL] [Abstract][Full Text] [Related]
11. Muscle-invasive Urothelial Cancer: Association of Mutational Status with Metastatic Pattern and Survival.
Alessandrino F; Williams K; Nassar AH; Gujrathi R; Silverman SG; Sonpavde G; Shinagare AB
Radiology; 2020 Jun; 295(3):572-580. PubMed ID: 32228295
[TBL] [Abstract][Full Text] [Related]
12. Quantitative detections of TP53 gene mutations improve the diagnosis and prognostic prediction of biliary tract cancers using droplet digital PCR.
Xiao X; Zhou J; Fang M; Ji J; Huang C; Du F; Ai W; Wang Y; Gao Z; Qiu Z; Gao C
J Clin Lab Anal; 2022 Jan; 36(1):e24103. PubMed ID: 34813121
[TBL] [Abstract][Full Text] [Related]
13. Exome sequencing of 22 genes using tissue from patients with biliary tract cancer.
Høgdall D; Larsen OF; Linnemann D; Svenstrup Poulsen T; Høgdall EV
APMIS; 2020 Jan; 128(1):3-9. PubMed ID: 31628675
[TBL] [Abstract][Full Text] [Related]
14. Survival of surgery for recurrent biliary tract cancer: a single-center experience and systematic review of literature.
Miyazaki Y; Kokudo T; Amikura K; Kageyama Y; Takahashi A; Ohkohchi N; Sakamoto H
Jpn J Clin Oncol; 2017 Mar; 47(3):206-212. PubMed ID: 27940488
[TBL] [Abstract][Full Text] [Related]
15. Biliary cancer: Utility of next-generation sequencing for clinical management.
Javle M; Bekaii-Saab T; Jain A; Wang Y; Kelley RK; Wang K; Kang HC; Catenacci D; Ali S; Krishnan S; Ahn D; Bocobo AG; Zuo M; Kaseb A; Miller V; Stephens PJ; Meric-Bernstam F; Shroff R; Ross J
Cancer; 2016 Dec; 122(24):3838-3847. PubMed ID: 27622582
[TBL] [Abstract][Full Text] [Related]
16. Genomic Profiling of Biliary Tract Cancers and Implications for Clinical Practice.
Jain A; Kwong LN; Javle M
Curr Treat Options Oncol; 2016 Nov; 17(11):58. PubMed ID: 27658789
[TBL] [Abstract][Full Text] [Related]
17. Brain Metastases from Biliary Tract Cancer: Case Series and Clinicogenomic Analysis.
Dodoo GN; De B; Lee SS; Abi Jaoude J; Vauthey JN; Tzeng CD; Tran Cao HS; Katlowitz KA; Mandel JJ; Beckham TH; Minsky BD; Smith GL; Holliday EB; Koong AC; Das P; Taniguchi CM; Javle M; Koay EJ; Ludmir EB
Oncologist; 2023 Apr; 28(4):327-332. PubMed ID: 36715178
[TBL] [Abstract][Full Text] [Related]
18. Prognostic impact of TP53 mutation status for adult patients with supratentorial World Health Organization Grade II astrocytoma or oligoastrocytoma: a long-term analysis.
Ständer M; Peraud A; Leroch B; Kreth FW
Cancer; 2004 Sep; 101(5):1028-35. PubMed ID: 15329912
[TBL] [Abstract][Full Text] [Related]
19. Outcomes in biliary malignancy.
Groot Koerkamp B; Fong Y
J Surg Oncol; 2014 Oct; 110(5):585-91. PubMed ID: 25250887
[TBL] [Abstract][Full Text] [Related]
20. Genomic spectra of biliary tract cancer.
Nakamura H; Arai Y; Totoki Y; Shirota T; Elzawahry A; Kato M; Hama N; Hosoda F; Urushidate T; Ohashi S; Hiraoka N; Ojima H; Shimada K; Okusaka T; Kosuge T; Miyagawa S; Shibata T
Nat Genet; 2015 Sep; 47(9):1003-10. PubMed ID: 26258846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
